NCT02110303View on ClinicalTrials.gov

DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 26, 2017

Study Completion Date

April 30, 2018

Conditions

Coronary Artery Disease

Interventions

DRUG

Ticagrelor

oral, 90mg tablets, twice daily, 12 month duration

DRUG

Placebo

Oral tablet (identical to ticagrelor), twice daily, 12 month duration

Trial Locations (1)

EH16 4SA

Edinburgh Heart Centre, Edinburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

University of Edinburgh

OTHER